Eversept Partners, LP - ELEDON PHARMACEUTICALS INC ownership

ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$154,454
-17.4%
67,7430.0%0.01%
-12.5%
Q3 2022$186,971
+29.7%
67,743
+14.7%
0.02%
+60.0%
Q2 2022$144,119
-67.9%
59,065
-48.2%
0.01%
-70.6%
Q1 2022$449,192
-10.7%
114,0080.0%0.03%
+6.2%
Q4 2021$502,775
-28.6%
114,0080.0%0.03%
-34.7%
Q3 2021$704,569114,0080.05%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CM Management, LLC 234,803$321,6800.34%
BVF INC/IL 4,326,710$5,927,5930.16%
ARMISTICE CAPITAL, LLC 1,824,000$2,498,8800.04%
SVB FINANCIAL GROUP 13,472$18,4570.04%
JMAC ENTERPRISES LLC 58,041$79,5160.02%
Woodline Partners LP 603,993$827,4700.01%
INGALLS & SNYDER LLC 51,849$710.00%
Ensign Peak Advisors, Inc 443,001$606,9110.00%
MILLENNIUM MANAGEMENT LLC 27,150$37,1960.00%
Curi RMB Capital, LLC 10,000$13,7000.00%
View complete list of ELEDON PHARMACEUTICALS INC shareholders